Preliminary Safety Results from the Phase IIIb GREEN Study of Obinutuzumab (GA101) Alone or in Combination with Chemotherapy for Previously Untreated or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Tarih

2014

Yazar

Bosch, Francesc
Illmer, Thomas
Turgut, Mehmet
Cortelezzi, Agostino
Lasserre, Susan F.
Truppel-Hartmann, Anna
Stilgenbauer, Stephan

Üst veri

Tüm öğe kaydını göster

Özet

…

Kaynak

Blood

Cilt

124

Sayı

21

Bağlantı

https://doi.org/10.1182/blood.V124.21.3345.3345
https://hdl.handle.net/20.500.12712/14833

Koleksiyonlar